MYLAN INC. v. SMITHKLINE BEECHAM CORP.

No. 12-1539.

723 F.3d 413 (2013)

MYLAN INC.; Mylan Pharmaceuticals Inc., Appellants v. SMITHKLINE BEECHAM CORPORATION, n/k/a Glaxosmithkline LLC, d/b/a Glaxosmithkline; Smithkline Beecham P.L.C., n/k/a Smithkline Beecham, Limited; Smithkline Beechman (Cork) Limited, successor to SB Pharmco Puerto Rico, Inc.; Apotex Inc; and Apotex Corporation.

United States Court of Appeals, Third Circuit.

Opinion Filed: July 22, 2013.


Attorney(s) appearing for the Case

Gary D. Adamson, Esquire , Michael E. Johnson, Esquire , (Argued), Alston & Bird, New York, NY, for Appellants.

William H. Burgess, Esquire , F. Christopher Mizzo, Esquire , (Argued), Michael A. Pearson, Esquire , Kirkland & Ellis, Washington, DC, Thomas A. Cunniff, Esquire , Fox Rothschild, Lawrenceville, NJ, Eric I. Abraham, Esquire , (Argued), Christina L. Saveriano, Esquire , Hill Wallack, Princeton, NJ, for Appellees.

Before: SCIRICA, AMBRO, and FUENTES, Circuit Judges.


OPINION OF THE COURT

AMBRO, Circuit Judge.

This case involves competing rights over the pharmaceutical paroxetine hydrochloride controlled release tablets ("paroxetine") in generic form. Defendant/Appellee GSK1 holds patent and FDA rights to market and sell paroxetine for the treatment of depression under the brand name Paxil CR.2 As part of a 2007 settlement agreement, GSK granted Plaintiff/Appellant...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases